Spots Global Cancer Trial Database for localized malignant mesothelioma
Every month we try and update this database with for localized malignant mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | NCT00005636 | Malignant Mesot... | cisplatin pemetrexed diso... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma | NCT00354393 | Malignant Mesot... | Cisplatin Methotrexate Vinorelbine dit... Adjuvant therap... Conventional su... Neoadjuvant The... 3-dimensional c... Intensity-modul... | - 75 Years | The Cleveland Clinic | |
| Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma | NCT00458913 | Malignant Mesot... | bortezomib cisplatin | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00227630 | Malignant Mesot... | cisplatin pemetrexed diso... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma | NCT00003974 | Lung Cancer Malignant Mesot... | lung tumor asso... DetoxPC chemotherapy cyclophosphamid... | 20 Years - 70 Years | Roswell Park Cancer Institute | |
| Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma | NCT00054002 | Malignant Mesot... | adjuvant therap... conventional su... porfimer sodium | 18 Years - | Roswell Park Cancer Institute | |
| Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | NCT00024271 | Malignant Mesot... | recombinant int... cisplatin doxorubicin hyd... gemcitabine hyd... mitomycin C conventional su... hyperthermia tr... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | NCT00004254 | Malignant Mesot... | raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | NCT00005636 | Malignant Mesot... | cisplatin pemetrexed diso... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia | NCT00899613 | Malignant Mesot... Metastatic Canc... | laboratory biom... study of high r... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery | NCT00253409 | Malignant Mesot... | chemotherapy adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura | NCT00004920 | Malignant Mesot... | cisplatin raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery | NCT00309946 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | cediranib malea... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma | NCT00354393 | Malignant Mesot... | Cisplatin Methotrexate Vinorelbine dit... Adjuvant therap... Conventional su... Neoadjuvant The... 3-dimensional c... Intensity-modul... | - 75 Years | The Cleveland Clinic | |
| Capecitabine in Treating Patients With Malignant Mesothelioma | NCT00004183 | Malignant Mesot... | capecitabine | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00075699 | Malignant Mesot... | cisplatin mitomycin C vincristine sul... vinorelbine tar... pain therapy psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Pazopanib in Treating Patients With Malignant Pleural Mesothelioma | NCT00459862 | Advanced Malign... Localized Malig... Recurrent Malig... | laboratory biom... pazopanib hydro... | 18 Years - | National Cancer Institute (NCI) | |
| EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer | NCT00028782 | Advanced Malign... Localized Malig... Malignant Ascit... Primary Periton... Recurrent Malig... | etanidazole therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma | NCT00027703 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | gemcitabine hyd... cisplatin bevacizumab placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma | NCT00458913 | Malignant Mesot... | bortezomib cisplatin | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | NCT00066404 | Cancer | recombinant ade... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | NCT00004254 | Malignant Mesot... | raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery | NCT00309946 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | cediranib malea... | 18 Years - | National Cancer Institute (NCI) | |
| Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | NCT00066404 | Cancer | recombinant ade... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma | NCT00030459 | Malignant Mesot... | cisplatin mitomycin C vinblastine sul... vinorelbine tar... | - | National Cancer Institute (NCI) | |
| Pazopanib in Treating Patients With Malignant Pleural Mesothelioma | NCT00459862 | Advanced Malign... Localized Malig... Recurrent Malig... | laboratory biom... pazopanib hydro... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
